IJPR  artciles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 1.55 (2012 - 2016). 

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
PIPPHARMACON & IJPR 2018

PIPPHARMACON & IJPR 2018

Click to download
 

Article Detail

Label
Label
Estimation of Apolipoprotein A, Apo B, Apo E and SomeBiochemical Markers in Type 2 Diabetic Patients in Iraq

Author: HUDA JABER, MOHAMMED ABDULJALIL, HAYDER ALKURAISHY
Abstract: Insulin resistance association with obesity and diabetes is described by rise the plasma TG-rich lipoprotein levels. Apolipoprotein (apo) plays a major role in the lipid metabolism and lipoproteins transport.The study was designed to investigate the levels of several type of Apolipoprotein ( Apo A, Apo B and Apo E) and other biochemical markers in type 2 diabetic patients and their relation with development of diabetic complications.Total of (40) patients of T2DM were selected in the study. For comparison, thirty healthy subject were enrolled in the study. Serum Apo A, Apo B and Apo E was measured. Other biochemical markers also determined which include serum C-peptide, glycosylated hemoglobin, FBS and lipid profile.Type 2 diabetic patients had significantly higher levels of Apo A than matched controls (270±72 vs.160±26 mg/dl, <0.0001), as well as, serum Apo E levels significantly increase in diabetic patients when compare to control group, while serum Apo B considerable higher in patients compared to control but the difference was not statistically significant. Plasma triglycerides were positively and independently correlated with Apo A levels. In conclusion, Apo A and Apo E can be used to follow diabetes and its complications
Keyword: Type 2 diabetes, Apolipoprotein A, Apo B, Apo E , C-peptide
EOI: http://eoi.citefactor.org/10.11209/ijpr.10.03.004
Download: Request For Article
 












USER LOGIN


Username
Password
Login | Register
AICTE INTERNATIONAL CONFERENCE

AICTE Sponsored International Conference on Challenges, Opportunities and Newer Directions of Pharmacovigilance and Clinical Research in India

Download Brochure


For More Detail Visit www.pippharmacon.org
News & Events
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus
Impact Factor for five years is 1.55 (2012 - 2016)
Year 2011 - 2015 Impact Factor - 1.46 Total Publications - 326 Total Citations - 477